MIRIAM KRAVITZ: Open Payments
NPI 1376614859 · ORLEANS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 61 payments from 9 companies in 2025. Trend: 2023 $568 · 2024 $1,018 · 2025 $971
Food & beverage: $881Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $351 |
| Janssen Biotech, Inc. | 14 | $275 |
| GENZYME CORPORATION | 4 | $102 |
| Regeneron Healthcare Solutions, Inc. | 4 | $97 |
| Biofrontera Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| LEO Pharma Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Sotyktu, ADBRY, AYVAKIT, COSENTYX, JUBLIA.
Industry payments across MA — which companies pay providers there.
